[113 Pages Report] Endoscopic vessel harvesting devices are used to obtain one or more healthy vessels from the patient's leg or arm to use as conduits to bypass obstructed blood vessel in the cardiac or peripheral region. Endoscopic vessel harvesting devices include EVH systems, endoscopes, and accessories. The global market is projected to reach USD 504.8 Million by 2022 from an estimated USD 406.6 Million in 2016, at a CAGR of 3.7% during the forecast period. Base year considered for the report is 2016. Forecast period considered for the report is 20172022.

Growth in the market is driven by factors such as increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population.

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast size of market segments with respect to the four key regionsNorth America, Europe, Asia Pacific, and RoW

To analyze the market structure and profile key players of the global market and comprehensively analyze their core competencies

To analyze the competitive landscape of the major players operating in the market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as, American Heart Association (AHA), World Health Organization (WHO), International Diabetes Federation (IDF), Centers for Medicare & Medicaid Services (CMS), European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD), Asian Pacific Society of Cardiology (APSC), Asian Society for Cardiovascular & Thoracic Surgery (ASCVTS), Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA), Society of Thoracic Surgeons (STS), Press Releases, directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Product Analysis

Company Information

The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population.

The market is segmented on the basis of product, usability, vessel type, application, and region. On the basis of product, the global market is segmented into EVH systems, endoscopes, and accessories. The EVH systems segment accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. This can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposable nature of these products.

Based on usability, the market is segmented into disposable and reusable. In 2017, the disposable segment commanded the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period primarily due to the rising preference for disposable devices over reusable owing to the advantages offered.

Based on vessel type, the market is segmented into saphenous vein and radial artery. The saphenous vein segment is expected to register highest CAGR during the forecast period. This can be attributed to the advantages offered by saphenous vein in terms of wound complications, reduced pain, and aesthetics.

Based on application, the market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment is expected to register the highest CAGR during the forecast period primarily due to the rising prevalence of cardiovascular diseases and increasing geriatric population.

The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high burden of cardiovascular diseases (CVDs), the launch of the Hospital Readmissions Reduction Program (HRRP) and Episode-based Payment Models (EPMs), increasing incidence of cardiac diseases, and growing preference for minimally invasive harvesting procedures.

The availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH is expected to restrain the growth of this market during the forecast period.